New Photocatalytic Coupling Reactions to Prepare Bioactive Molecules
New Photocatalytic Coupling Reactions to Prepare Bioactive Molecules
批准号:
10620275
负责人:
David Martin
金额:
$37.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-08-01 至 2025-05-31
关键词:
AdamantaneAlcoholsAlzheimer&aposs DiseaseBiochemistryBiologicalChemicalsClinicalCobaltComplexCouplingDevelopmentExhibitsFamilyGoalsGuidelinesInvestigationLightLipidsMedicineMethodsNatural ProductsNerve DegenerationPathway interactionsPharmaceutical PreparationsProcessReactionReportingResearchResearch PersonnelTechnologyTerpenesTestingTherapeutic InterventionVirus DiseasesVitamin B 12bioactive natural productscatalystdesignhuman diseaseinsightnatural product derivativeneuroprotectionnovelnovel therapeuticspharmacophoreprogramsscaffold
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overarching goal of this research program is to discover new catalytic methods for the synthesis of
biologically active targets, both natural and unnatural. We have previously reported the synthesis of phenolic
lipid natural products and efforts toward two families of polycyclic terpenes, as well as a general process for
the synthesis of the cobalt complexes used in the photocatalytic investigations described in Project 2. The
targets described in this proposal include molecules that will serve as mechanistic probes to study
neurodegeneration and viral diseases, as well as leads that may provide new therapeutic opportunities. We are
investigating methods to target specific structural motifs with established biological activity, such as amino-adamantanes
and limonoid natural products, as well as catalytic methods designed to apply to a broad
spectrum of chemical targets. The enabling technology behind these methods is photocatalysis, which
harnesses light energy to drive complex catalytic processes. Photocatalysis continues to provide new
mechanisms and transformations that are difficult or impossible to access otherwise. Understanding the
governing principles of these processes allows us to apply that insight to the discovery of new, broadly useful
synthesis methods.
Substituted adamantanes appear in a wide variety of molecules with important function including
clinically approved drugs for Alzheimer’s dementia and viral diseases, however efficient synthesis remains a
challenge. In Project 1, new amino-adamantane derivatives will be accessed through a new aminoalkylation
reaction and new catalytic strategies that enable unique selectivity that is complementary to existing
approaches. The unique strategies described here include a detailed study of the selectivity of new and
established H-atom transfer methods, providing guidelines necessary for selecting the proper HAT catalyst for
different substrate classes. In Project 2, a novel polar/radical crossover manifold inspired by the biochemistry
of vitamin B12 will be developed for the efficient use of inexpensive and readily available alcohols for bioactive
molecule construction. These methods will be applied to the synthesis of promising natural product targets
such as the neuroprotective limonoids. The investigation of the neuroprotective activity of limonoids is of
central importance, therefore alternative pathways will be explored to access to these molecules and
derivatives for mechanism of action studies. Overall, the concepts described here will provide general
platforms for the rapid construction of pharmacophores and bioactive natural product derivatives that can be
immediately deployed by biomedical researchers.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1039/d1ob01916c
发表时间:
2021-12-22
期刊:
Organic & biomolecular chemistry
影响因子:
3.2
作者:
[]
通讯作者:
New Photocatalytic Coupling Reactions to Prepare Bioactive Molecules
-
批准号:10218222
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2020
-
负责人:David Martin
-
依托单位:
New Photocatalytic Coupling Reactions to Prepare Bioactive Molecules
-
批准号:10028168
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2020
-
负责人:David Martin
-
依托单位:
New Photocatalytic Coupling Reactions to Prepare Bioactive Molecules
-
批准号:10417169
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2020
-
负责人:David Martin
-
依托单位:
海外基金